Instytut Kształcenia Podyplomowego w Zakresie Nauk i Badań Medycznych, Czandigarh, Indie. Instytut Zdrowia Ogólnego George’a, Nowe Delhi, Indie. Uniwersytet Oksfordzki, Oksford, Wielka Brytania
References
1. Pugsley D, Norris KC, Garcia-Garcia G et al.: Global approaches for understanding the disproportionate burden of chronic kidney disease. Ethn Dis 2009; 19 (Suppl. 1): S1-1–S1-2.
2. Crews DC, Charles RF, Evans MK et al.: Poverty, race, and CKD in a racially and socioeconomically diverse urban population. Am J Kidney Dis 2010; 55: 992-1000.
3. Sachs JD: Macroeconomics and health: investing in health for economic development. Report of the Commission on Macroeconomics and Health of the WHO 2001.
4. Kalantar-Zadeh K, Block G, Humphreys MH et al.: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003; 63: 793-808.
5. Hsu CY, Lin F, Vittinghof E et al.: Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 2003; 14: 2902-2907.
6. Norris K, Nissenson AR: Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol 2008; 19: 1261-1270.
7. Bruce MA, Beech BM, Crook ED et al.: Association of socioeconomic status and CKD among African Americans: the Jackson Heart Study. Am J Kidney Dis 2010; 55: 1001-1008.
8. Volkova N, McClellan W, Klein M et al.: Neighborhood poverty and racial differences in ESRD incidence. J Am Soc Nephrol 2008;19: 356-364.
9. Caskey FJ: Renal replacement therapy: can we separate the effects of social deprivation and ethnicity? Kidney Int Suppl 2013; 3: 246-249.
10. Sabanayagam C, Lim SC, Wong TY et al.: Ethnic disparities in prevalence and impact of risk factors of chronic kidney disease. Nephrol Dial Transplant 2010; 25: 2564-2570.
11. Gao S, Manns BJ, Culleton BF et al.: Prevalence of chronic kidney disease and survival among Aboriginal people. J Am Soc Nephrol 2007; 18: 2953-2959.
12. McDonald S: Incidence and treatment of ESRD among indigenous peoples of Australasia. Clin Nephrol 2010; 74 (Suppl. 1): S28-S31.
13. Collins JF: Kidney disease in Maori and Pacific people in New Zealand. Clin Nephrol 2010; 74 (Suppl. 1): S61-S65.
14. Weil EJ, Nelson RG: Kidney disease among the indigenous peoples of Oceania. Ethn Dis 2006; 16 (Suppl. 2): S2-24-S2-30.
15. United States Renal Data System: 2006 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda 2013.
16. Kasiske BL, Rith-Najarian S, Casper ML et al.: American Indian heritage and risk factors for renal injury. Kidney Int 1998; 54: 1305-1310.
17. Nelson RG, Morgenstern H, Bennett PH: An epidemic of proteinuria in Pima Indians with type 2 diabetes mellitus. Kidney Int 1998; 54: 2081-2088.
18. Scavini M, Shah VO, Stidley CA et al.: Kidney disease among the Zuni Indians: the Zuni Kidney Project. Kidney Int Suppl 2005; 68: S126-S131.
19. Jha V, Garcia-Garcia G, Iseki K et al.: Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382: 260-272.
20. Almaguer M, Herrera R, Orantes CM: Chronic kidney disease of unknown etiology in agricultural communities. MEDICC Rev 2014; 16: 9-15.
21. Ulasi II, Ijoma CK, Onodugo OD et al.: Towards prevention of chronic kidney disease in Nigeria; a community-based study in Southeast Nigeria. Kidney Int Suppl 2013; 3: 195-201.
22. Otieno LS, McLigeyo SO, Luta M: Acute renal failure following the use of herbal medicines. East Afr Med J 1991; 6: 993-998.
23. Obrador GT, Garcia-Garcia G, Villa AR et al.: Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) Mexico and comparison with KEEP US. Kidney Int Suppl 2010; 116: S2-S8.
24. Gutierrez-Padilla JA, Mendoza-Garcia M, Plascencia-Perez S et al.: Screening for CKD and cardiovascular disease risk factors using mobile clinics in Jalisco, Mexico. Am J Kidney Dis 2010; 55: 474-484.
25. Garcia-Garcia G, Gutierrez-Padilla AJ, Chavez-Iniguez J et al.: Identifying undetected cases of chronic kidney disease in Mexico. Targeting high-risk populations. Arch Med Res 2013; 44: 623-627.
26. Amato D, Alvarez-Aguilar C, Castaneda-Limones R et al.: Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int Suppl 2005; 97: S11-S17.
27. Hoy W, McDonald SP: Albuminuria: marker or target in indigenous populations. Kidney Int Suppl 2004; 92: S25-S31.
28. McDonald SP, Maguire GP, Hoy WE: Renal function and cardiovascular risk markers in a remote Australian Aboriginal community. Nephrol Dial Transplant 2003; 18: 1555-1561.
29. Hoy WE, Samuel T, Mott SA et al.: Renal biopsy findings among Indigenous Australians: a nationwide review. Kidney Int 2012; 82: 1321-1331.
30. Hoy WE, Hughson MD, Zimanyi M et al.: Distribution of volumes of individual glomeruli in kidneys at autopsy: association with age, nephron number, birth weight and body mass index. Clin Nephrol 2010; 74 (Suppl. 1): S105-S112.
31. Lackland DT, Bendall HE, Osmond C et al.: Low birth weights contribute to high rates of early-onset of chronic renal failure in the Southeastern United States. Arch Intern Med 2000; 160: 1472-1476.
32. Bhargava SK, Sachdev HS, Fall CH et al.: Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med 2004; 350: 865-875.
33. Jafar TH, Chaturvedi N, Hatcher J et al.: Proteinuria in South Asian children: prevalence and determinants. Pediatr Nephrol 2005; 20: 1458-1465.
34. Jafar TH, Islam M, Poulter N et al.: Children in South Asia have higher body mass-adjusted blood pressure levels than white children in the United States: a comparative study. Circulation 2005; 111:1291-1297.
35. Liyanage T, Ninomiya T, Jha V et al.: Worldwide access to treatment for end stage kidney disease: a systematic review (submitted).
36. Barsoum RS: Chronic kidney disease in the developing world. N Engl J Med 2006; 354: 997-999.
37. Cusumano AM, Garcia-Garcia G, Gonzalez-Bedat MC et al.: Latin American Dialysis and Transplant Registry: 2008 prevalence and incidence of end-stage renal disease and correlation with socioeconomic indexes. Kidney Int Suppl 2013; 3: 153-156.
38. Jha V: Current status of end-stage renal disease care in India and Pakistan. Kidney Int Suppl 2013; 3: 157-160.
39. Garcia GG, Harden P, Chapman J; World Kidney Day Steering Committee 2012: The global role of kidney transplantation. Lancet 2012; 379: e36-e38.
40. Yeates KE, Cass A, Sequist TD et al.: Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation. Kidney Int 2009; 76: 659-664.
41. Jha V: Current status of chronic kidney disease care in southeast Asia. Semin Nephrol 2009; 29: 487-496.
42. Garcia-Garcia G, Monteon-Ramos JF, Garcia-Bejarano H et al.: Renal replacement therapy among disadvantaged populations in Mexico: a report from the Jalisco Dialysis and Transplant Registry (REDTJAL). Kidney Int Suppl 2005; 97: S58-S61.
43. Ramachandran R, Jha V: Kidney transplantation is associated with catastrophic out of pocket expenditure in India. PLoS One 2013; 8: e67812.
44. McDonald SP, Russ GR: Burden of end-stage renal disease among indigenous peoples in Australia and New Zealand. Kidney Int Suppl 2003; 83: S123-S127.
45. Chou SH, Tonelli M, Bradley JS et al.: Quality of care among Aboriginal hemodialysis patients. Clin J Am Soc Nephrol 2006; 1: 58-63.
46. Rodriguez RA, Sen S, Mehta K et al.: Geography matters: relationships among urban residential segregation, dialysis facilities, and patient outcomes. Ann Intern Med 2007; 146: 493-501.
47. Mehrotra R, Story K, Guest S et al.: Neighborhood location, rurality, geography, and outcomes of peritoneal dialysis patients in the United States. Perit Dial Int 2012; 32: 322-331.
48. Garcia-Garcia G, Briseno-Renteria G, Luquin-Arellan VH et al.: Survival among patients with kidney failure in Jalisco, Mexico. J Am Soc Nephrol 2007; 18: 1922-1927.
49. Parameswaran S, Geda SB, Rathi M et al.: Referral pattern of patients with end-stage renal disease at a public sector hospital and its impact on outcome. Natl Med J India 2011; 24: 208-213.